| Literature DB >> 26438676 |
Paul W Blair1, Douglas Herrin1, Nawaf Abaalkhail1, Wesley Fiser1.
Abstract
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is characterised by fever, rash, eosinophilia and organ damage that develops 2-6 weeks after the initiation of a medication. We report a case of DRESS syndrome in a 79-year-old man that developed after the introduction of rifabutin, ethambutol and clarithromycin used to treat Mycobacterium avium complex (MAC) vertebral osteomyelitis. This case highlights treatment and management challenges in a patient with known MAC vertebral osteomyelitis requiring prolonged steroids. Steroids are the mainstays of treatment for moderate to severe cases of DRESS syndrome. Initiation of steroids for the treatment of DRESS syndrome among patients with concomitant infections requires multidisciplinary collaboration for optimal management. 2015 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26438676 PMCID: PMC4600809 DOI: 10.1136/bcr-2015-210907
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X